Literature DB >> 24034660

Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients.

Ivo Abraham1, Yoleen Van Camp, Lorenzo Villa, Kris Denhaerynck, Diana Sun, Stefaan Vancayzeele, Heidi Brié, Ann Aerts, Christine Hermans, Karen MacDonald.   

Abstract

The authors used pooled data from 6 valsartan-related studies including 3983 adherent and 10,663 nonadherent patients to evaluate blood pressure (BP) outcomes in both groups after 90 days of treatment, applying hierarchical linear and logistic regression to identify determinants of BP outcomes. The principal findings were that: (1) BP outcomes were consistently better in adherent patients; (2) approximately a quarter of the variance in 90-day BP values was attributable to a physician class effect; (3) common and unique patient- and physician-related variables were associated with BP outcomes in both groups; (4) physician vigilance was associated with better outcomes, especially in adherent patients; and (5) adherent patients were more likely to exhibit target organ damage and associated events while being prescribed more complex medication regimens. Adherence to antihypertensive medication may be a function of prior line treatment failure, severity of illness, and sequelae, and the ensuing patient resolution to change medication behavior. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24034660      PMCID: PMC8033854          DOI: 10.1111/jch.12163

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

Review 1.  The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review.

Authors:  Fabienne Dobbels; Lut Berben; Sabina De Geest; Gerda Drent; Annette Lennerling; Clare Whittaker; Christiane Kugler
Journal:  Transplantation       Date:  2010-07-27       Impact factor: 4.939

2.  Predictors of blood pressure control among hypertensives in community health centers.

Authors:  Donna Shelley; Tuo-Yen Tseng; Howard Andrews; Joseph Ravenell; Daren Wu; Pamela Ferrari; Asaf Cohen; Mari Millery; Helene Kopal
Journal:  Am J Hypertens       Date:  2011-08-25       Impact factor: 2.689

3.  Evaluation of a hypertension medication therapy management program in patients with diabetes.

Authors:  Lourdes G Planas; Kimberly M Crosby; Kimberly D Mitchell; Kevin C Farmer
Journal:  J Am Pharm Assoc (2003)       Date:  2009 Mar-Apr

4.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

5.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

6.  Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

Authors:  Bernard Vrijens; Gäbor Vincze; Paulus Kristanto; John Urquhart; Michel Burnier
Journal:  BMJ       Date:  2008-05-14

7.  Factors associated with drug adherence and blood pressure control in patients with hypertension.

Authors:  Andrew B Morris; Jingjin Li; Kurt Kroenke; Tina E Bruner-England; Jim M Young; Michael D Murray
Journal:  Pharmacotherapy       Date:  2006-04       Impact factor: 4.705

Review 8.  Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.

Authors:  James E Frampton; Lesley J Scott
Journal:  Am J Cardiovasc Drugs       Date:  2009       Impact factor: 3.571

Review 9.  ASH position paper: Adherence and persistence with taking medication to control high blood pressure.

Authors:  Martha N Hill; Nancy H Miller; Sabina DeGeest
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-09-16       Impact factor: 3.738

10.  Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients.

Authors:  Ivo Abraham; Yoleen Van Camp; Lorenzo Villa; Kris Denhaerynck; Diana Sun; Stefaan Vancayzeele; Heidi Brié; Ann Aerts; Christine Hermans; Karen MacDonald
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-12       Impact factor: 3.738

View more
  4 in total

1.  The evolving clinical management of hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738

2.  Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Hypertensive Patients with and without Diabetes: Pooled Analysis of Six Observational Valsartan Studies with 15,282 Evaluable Patients.

Authors:  Noha Ashy; Thanh-Nga Nguyen; Kris Denhaerynck; Mahdi Gharaibeh; Abdulaziz Alhossan; Stefaan Vancayzeele; Heidi Brié; Ann Aerts; Karen MacDonald; Ivo Abraham
Journal:  Int J Chronic Dis       Date:  2017-09-25

3.  Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients.

Authors:  Ivo Abraham; Yoleen Van Camp; Lorenzo Villa; Kris Denhaerynck; Diana Sun; Stefaan Vancayzeele; Heidi Brié; Ann Aerts; Christine Hermans; Karen MacDonald
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-12       Impact factor: 3.738

4.  Technologies for Innovative Monitoring to Reduce Blood Pressure and Change Lifestyle Using Mobile Phones in Adult and Elderly Populations (TIM Study): Protocol for a Randomized Controlled Trial.

Authors:  Sandra C Fuchs; Erno Harzheim; Cirano Iochpe; Caroline N de David; Marcelo R Gonçalves; Guilhermo P Sesin; Cassio M Costa; Leila B Moreira; Flavio D Fuchs
Journal:  JMIR Res Protoc       Date:  2018-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.